Author: aracila

Global NASH/MASH Council (GNC) Meeting at INASL 2025 Annual Conference

The Global NASH/MASH Council (GNC) convened a highly productive meeting during the 33rd Annual Conference of the Indian National Association for the Study of the Liver (INASL), held August 7–10, 2025, in Chandigarh, India. Focusing on the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in South and Southeast Asia, the 3.5-hour session brought together leading hepatology experts from across the region. Opening remarks were delivered by Professor Ajay Duseja (Secretary General, INASL), Professor Radha K. Dhiman (President, INASL), and Professor Zobair M. Younossi (Chairman, GNC). The meeting highlighted the escalating burden of MASLD/MASH and laid the groundwork for expanded regional and global collaboration. Discussions are expected to foster impactful partnerships to advance research, increase disease awareness, and improve treatment strategies not only within South and Southeast Asia, but also in other regions represented by the GNC.

Dimer Diabetes 2025, Bodrum, Turkey (October 26-29)

The Global NASH/MASH Council is delighted to collaborate with Dimer Diabetes 2025 which is a scientific meeting in Bodrum, Turkey with exceptional faculty and agenda. For more information about Dimer Diabetes 2025, please use the following link. https://www.dimerdiabetescenter.com/

The Global NASH/MASH and Global Liver Council Meetings During ILC 2025 in Amsterdam

GNC and GLC had another very successful meeting during ILC 2025 with over 70 members participating. The meeting was full of exciting reports related to the projects of different GNC/GLC committees. Additionally, an in-depth 3 hours meeting was dedicated to MASLD/SLD discussing NIT algorithms in clinical practice, awareness challenges, patient perspective about MASLD, preventive hepatology and Burden of Disease/Cost of Inaction for MASLD. These discussions will lead to more projects helping to move the field forward as well as recommendations to policy makers about actions that are needed to deal with MASLD at a global level.

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis, Gastroenterology, April 11, 2025

The Global NASH/MASH Council (GNC) has just published in Gastroenterology (April 11, 2025, In Press) the most comprehensive recommendations about MASLD and MASH. After systematically reviewing 61 guidelines and similar documents (2018-2025) and undertaking an extensive Delphi process, the Global Recommendations for MASLD/MASH provide the most updated clinically relevant information on all aspects of MASLD/MASH including risk stratification, diagnosis, lifestyle management and medical treatment to optimize person-centric care of MASLD/MASH. To see the full abstract, please click https://www.gastrojournal.org/article/S0016-5085(25)00632-8/fulltext Download PDF version

The Global NASH Council Meeting During APASL 2025, Beijing, China March 27, 2025

The Global NASH/MASH Council (GNC) meeting was held during APASL 2025 in Beijing, China. The meeting was co-chaired by Professor Zobair M. Younossi and Professor Jiangao Fan and was attended by over 50 members in person and another 12 via zoom. A number of important topics related to the disease burden, NITs, risk stratification and treatment of MASH in the Asian Pacific region were discussed by the highly respected international members of GNC. Additionally, GNC and its network of global collaborators discussed the ongoing research projects and expressed interest to continue to expand their projects to address Steatotic Liver Disease as one of the most important non-communicable diseases. The members continued their commitment to the Global registries maintained by GNC and the future collaborative projects. Professor Younossi and Professor Fan open the Global NASH/MASH Council-APASL 2025

The Fifth Annual Liver Connect, San Antonio, Texas (March 20-22,2025)

The Fifth Annual Liver Connect is being organized by Chronic Liver Disease Foundation (CLDF) in San Antonio, Texas (March 20-22,2025). This superb meeting covers cutting-edge information about most common liver diseases (MASH, viral hepatitis, ALD, cholestatic liver disease, complications of cirrhosis, HCC and pediatric liver disease) delivered by internationally renowned experts. The meeting will provide an opportunity to connect different stakeholders to advance the field of hepatology.